Author:
Metcalfe Kelly, ,Eisen Andrea,Senter Leigha,Armel Susan,Bordeleau Louise,Meschino Wendy S.,Pal Tuya,Lynch Henry T.,Tung Nadine M.,Kwong Ava,Ainsworth Peter,Karlan Beth,Moller Pal,Eng Charis,Weitzel Jeffrey N.,Sun Ping,Lubinski Jan,Narod Steven A.
Funder
Steven A. Narod is the recipient of a Canada Research Chair (Tier I). This work was supported the Peter Gilgan Foundation.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos-Blom, M. J. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317, 2402–2416 (2017).
2. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian: National Comprehensive Cancer Network. (2018).
3. Finch, A., Beiner, M., Lubinski, J., Lynch, H. T., Moller, P., Rosen, B. et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296, 185–192 (2006).
4. Finch, A. P., Lubinski, J., Moller, P., Singer, C. F., Karlan, B., Senter, L., et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J. Clin. Oncol. 32, 1547–1553 (2014).
5. Kriege, M., Brekelmans, C. T., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M. et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N. Engl. J. Med. 351, 427–437 (2004).
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献